Michael S. Jaffee MD
Neurorehabilitation, Sleep Medicine, Spinal Disorder, Dementia & Geriatrics
Vice-Chair, Department of Neurology
Join to View Full Profile
4740 NW 39th PlSte CGainesville, FL 32606
Phone+1 352-265-5240
Fax+1 352-627-4268
Dr. Jaffee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
San Antonio Uniformed Services Health Education ConsortiumFellowship, Sleep Medicine, 2010 - 2011- San Antonio Uniformed Services Health Education ConsortiumResidency, Neurology, 1995 - 1998
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Psychiatry, 1992 - 1995
University of Virginia School of MedicineClass of 1992
Certifications & Licensure
FL State Medical License 2015 - 2026
VA State Medical License 2013 - 2016
PA State Medical License 1998 - 2014
American Board of Psychiatry and Neurology Neurology- American Board of Psychiatry and Neurology Psychiatry
- American Board of Psychiatry and Neurology Brain Injury Medicine
- American Board of Psychiatry and Neurology Sleep Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- 1 citationsContinuous glucose monitoring and all-cause mortality in insulin-using population with diabetes and cognitive impairment.Pareeta Kotecha, Weihan Chen, William T Donahoo, Michael Jaffee, Jiang Bian
Diabetes, Obesity & Metabolism. 2024-10-01 - Association of education attainment, smoking status, and alcohol use disorder with dementia risk in older adults: a longitudinal observational study.Huilin Tang, C Elizabeth Shaaban, Steven T DeKosky, Glenn E Smith, Xia Hu
Alzheimer's Research & Therapy. 2024-09-18 - 3 citationsHeterogeneous treatment effects of sodium-glucose cotransporter 2 inhibitors on risk of dementia in people with type 2 diabetes: A population-based cohort study.Huilin Tang, William T Donahoo, Mikael Svensson, C Elizabeth Shaaban, Glenn Smith
Alzheimer's & Dementia. 2024-08-01
Press Mentions
Breakthrough AI Tech Enables at-Home Tracking of Parkinson’s Disease ProgressionAugust 11th, 2024- New Video Test Uses AI to Revolutionize Parkinson’s Disease TreatmentJuly 27th, 2024
At Any Age, Lack of Sleep Can Drag You DownMay 22nd, 2017
Grant Support
- Preclinical Markers of ParkinsonismUNIVERSITY OF FLORIDA2021–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
